Xiang Gao Selected Research

6-thioguanylic acid

10/2019	Nucleoside diphosphate-linked moiety X-type motif 15 R139C genotypes impact 6-thioguanine nucleotide cut-off levels to predict thiopurine-induced leukopenia in Crohn's disease patients.
1/2012	Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiang Gao Research Topics

Disease

167	Neoplasms (Cancer) 12/2022 - 01/2003
51	Inflammation (Inflammations) 12/2022 - 04/2004
41	Infections 12/2022 - 05/2007
41	Obesity 01/2022 - 10/2007
30	Breast Neoplasms (Breast Cancer) 12/2022 - 07/2003
27	Hypertension (High Blood Pressure) 03/2022 - 03/2007
27	Insulin Resistance 02/2022 - 04/2009
26	Crohn Disease (Crohn's Disease) 04/2022 - 06/2005
25	Body Weight (Weight, Body) 12/2022 - 10/2004
25	Neoplasm Metastasis (Metastasis) 12/2022 - 06/2004
25	Fibrosis (Cirrhosis) 01/2022 - 03/2006
23	Parkinson Disease (Parkinson's Disease) 01/2022 - 04/2008
18	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 06/2004
18	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 06/2005
16	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 01/2008
16	Carcinogenesis 01/2022 - 02/2009
15	Type 2 Diabetes Mellitus (MODY) 02/2022 - 10/2007
15	Ovarian Neoplasms (Ovarian Cancer) 06/2021 - 06/2011
15	Stroke (Strokes) 01/2021 - 03/2010
14	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2011
14	Myocardial Infarction 01/2021 - 10/2006
13	Glioma (Gliomas) 06/2022 - 12/2011
13	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2005
13	Carcinoma (Carcinomatosis) 06/2021 - 01/2011
13	Reperfusion Injury 01/2021 - 06/2007
12	Chronic Disease (Chronic Diseases) 12/2022 - 10/2006
12	Sepsis (Septicemia) 05/2022 - 02/2004
12	Myasthenia Gravis 01/2021 - 10/2010
11	Hypoxia (Hypoxemia) 01/2022 - 01/2013
11	Necrosis 01/2022 - 09/2010
11	Ischemia 01/2022 - 01/2007
11	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 07/2011
10	Lung Neoplasms (Lung Cancer) 06/2022 - 10/2007
10	Hypersensitivity (Allergy) 01/2022 - 01/2003
10	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 10/2008
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2021 - 03/2007
10	Hyperuricemia 01/2021 - 08/2007
10	Melanoma (Melanoma, Malignant) 01/2021 - 06/2004
9	Asthma (Bronchial Asthma) 03/2022 - 06/2008
9	Overweight 01/2022 - 01/2016
9	Wounds and Injuries (Trauma) 01/2022 - 01/2012
9	Hyperglycemia 01/2022 - 04/2009
9	Cerebral Hemorrhage 10/2020 - 03/2015
9	Cognitive Dysfunction 09/2020 - 08/2010
9	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 07/2011
8	Pneumonia (Pneumonitis) 05/2022 - 05/2002
8	Pain (Aches) 04/2022 - 05/2012
8	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2007
8	Glucose Intolerance 03/2021 - 05/2009
8	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018 - 05/2007
8	Infarction (Infarctions) 11/2017 - 02/2004

Drug/Important Bio-Agent (IBA)

88	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2003
39	Pharmaceutical PreparationsIBA 06/2022 - 01/2003
38	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 03/2007
34	LipidsIBA 12/2021 - 04/2009
30	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2010
29	CytokinesIBA 12/2022 - 05/2002
26	Messenger RNA (mRNA)IBA 08/2022 - 05/2007
24	CholesterolIBA 12/2022 - 03/2007
23	MicellesIBA 06/2022 - 01/2012
19	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2011
19	Uric Acid (Urate)IBA 01/2021 - 01/2008
18	Insulin (Novolin)FDA Link 03/2021 - 05/2009
17	Peptides (Polypeptides)IBA 06/2022 - 01/2003
16	C-Reactive ProteinIBA 01/2022 - 01/2014
15	LigandsIBA 11/2022 - 01/2003
15	Biological ProductsIBA 01/2022 - 10/2006
14	LDL CholesterolIBA 12/2022 - 10/2007
14	MicroRNAs (MicroRNA)IBA 08/2022 - 01/2018
14	AntioxidantsIBA 05/2022 - 10/2004
13	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2005
12	HDL CholesterolIBA 12/2022 - 08/2008
12	methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA 10/2020 - 01/2012
11	Triglycerides (Triacylglycerol)IBA 12/2022 - 08/2008
11	AntigensIBA 06/2022 - 01/2003
11	AntibodiesIBA 06/2022 - 06/2005
11	VaccinesIBA 08/2021 - 05/2007
10	EnzymesIBA 05/2022 - 10/2009
10	Therapeutic UsesIBA 01/2020 - 07/2011
9	2-mercaptopurineIBA 04/2022 - 01/2012
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 01/2005
9	oxidized low density lipoproteinIBA 03/2022 - 01/2013
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 07/2009
9	CateninsIBA 01/2022 - 12/2010
9	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
9	Caspase 3 (Caspase-3)IBA 11/2021 - 12/2014
9	Caffeine (No Doz)FDA LinkGeneric 01/2021 - 11/2011
9	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 02/2013
8	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 01/2009
8	Hemoglobins (Hemoglobin)IBA 12/2022 - 01/2017
8	Small Interfering RNA (siRNA)IBA 11/2021 - 10/2008
8	Interleukin-6 (Interleukin 6)IBA 08/2021 - 02/2011
8	NF-kappa B (NF-kB)IBA 01/2021 - 05/2002
8	GlucocorticoidsIBA 01/2021 - 07/2011
8	CalciumIBA 06/2020 - 12/2005

Therapy/Procedure

110	Therapeutics 12/2022 - 10/2006
15	Drug Therapy (Chemotherapy) 01/2021 - 01/2009
13	Immunotherapy 06/2022 - 08/2011
10	Ligation 05/2022 - 10/2006
10	Radiotherapy 01/2021 - 06/2003